Finding the sweet spot: the role of nature and nurture in medicinal chemistry

被引:303
作者
Hann, Michael M. [2 ]
Keserue, Gyoergy M. [1 ]
机构
[1] Gedeon Richter, Dept Discovery Chem, H-1103 Budapest, Hungary
[2] GlaxoSmithKline Med Res Ctr, Dept Computat & Struct Chem, Stevenage SG6 3LB, Herts, England
关键词
DRUG DISCOVERY; LEAD DISCOVERY; DEVELOPMENT PRODUCTIVITY; MOLECULAR COMPLEXITY; LIGAND EFFICIENCY; PROPERTY PROFILES; THERMODYNAMICS; LIPOPHILICITY; BINDING; IMPACT;
D O I
10.1038/nrd3701
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Given its position at the heart of small-molecule drug discovery, medicinal chemistry has an important role in tackling the well-known productivity challenges in pharmaceutical research and development. In recent years, extensive analyses of successful and failed discovery compounds and drug candidates have improved our understanding of the role of physicochemical properties in drug attrition. Based on the clarified challenges in finding the 'sweet spot' in medicinal chemistry programmes, we suggest that this goal can be achieved through a combination of first identifying chemical starting points with appropriate 'nature' and then rigorously 'nurturing' them during lead optimization. Here, we discuss scientific, strategic, organizational and cultural considerations for medicinal chemistry practices, with the aim of promoting more effective use of what is already known, as well as a wider appreciation of the risks of pursuing suboptimal compounds.
引用
收藏
页码:355 / 365
页数:11
相关论文
共 74 条
[51]   Opinion - How many drug targets are there? [J].
Overington, John P. ;
Al-Lazikani, Bissan ;
Hopkins, Andrew L. .
NATURE REVIEWS DRUG DISCOVERY, 2006, 5 (12) :993-996
[52]   Global mapping of pharmacological space [J].
Paolini, Gaia V. ;
Shapland, Richard H. B. ;
van Hoorn, Willem P. ;
Mason, Jonathan S. ;
Hopkins, Andrew L. .
NATURE BIOTECHNOLOGY, 2006, 24 (07) :805-815
[53]   How to improve R&D productivity: the pharmaceutical industry's grand challenge [J].
Paul, Steven M. ;
Mytelka, Daniel S. ;
Dunwiddie, Christopher T. ;
Persinger, Charles C. ;
Munos, Bernard H. ;
Lindborg, Stacy R. ;
Schacht, Aaron L. .
NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (03) :203-214
[54]   Heteroaromatic Rings of the Future [J].
Pitt, William R. ;
Parry, David M. ;
Perry, Benjamin G. ;
Groom, Colin R. .
JOURNAL OF MEDICINAL CHEMISTRY, 2009, 52 (09) :2952-2963
[55]   Ligand binding efficiency: Trends, physical basis, and implications [J].
Reynolds, Charles H. ;
Tounge, Brett A. ;
Bembenek, Scott D. .
JOURNAL OF MEDICINAL CHEMISTRY, 2008, 51 (08) :2432-2438
[56]   Thermodynamics of Ligand Binding and Efficiency [J].
Reynolds, Charles H. ;
Holloway, M. Katharine .
ACS MEDICINAL CHEMISTRY LETTERS, 2011, 2 (06) :433-437
[57]   The Medicinal Chemist's Toolbox: An Analysis of Reactions Used in the Pursuit of Drug Candidates [J].
Roughley, Stephen D. ;
Jordan, Allan M. .
JOURNAL OF MEDICINAL CHEMISTRY, 2011, 54 (10) :3451-3479
[58]   Shielded Hydrogen Bonds as Structural Determinants of Binding Kinetics: Application in Drug Design [J].
Schmidtke, Peter ;
Javier Luque, F. ;
Murray, James B. ;
Barril, Xavier .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (46) :18903-18910
[59]   Mechanism of the hydrophobic effect in the biomolecular recognition of arylsulfonamides by carbonic anhydrase [J].
Snyder, Phillip W. ;
Mecinovic, Jasmin ;
Moustakas, Demetri T. ;
Thomas, Samuel W., III ;
Harder, Michael ;
Mack, Eric T. ;
Lockett, Matthew R. ;
Heroux, Annie ;
Sherman, Woody ;
Whitesides, George M. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2011, 108 (44) :17889-17894
[60]   Analysis of in vitro bioactivity data extracted from drug discovery literature and patents: Ranking 1654 human protein targets by assayed compounds and molecular scaffolds [J].
Southan, Christopher ;
Boppana, Kiran ;
Jagarlapudi, Sarma A. R. P. ;
Muresan, Sorel .
JOURNAL OF CHEMINFORMATICS, 2011, 3